本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

100.57
+1.161.16%
成交量:34.32万
成交额:3,468.58万
市值:67.11亿
市盈率:-32.38
高:101.98
开:99.85
低:99.57
收:99.41
52周最高:116.00
52周最低:45.91
股本:6,673.61万
流通股本:5,341.51万
量比:0.68
换手率:0.64%
股息:- -
股息率:- -
每股收益(TTM):-3.1057
每股收益(LYR):-4.3376
净资产收益率:-85.79%
总资产收益率:-26.74%
市净率:45.10
市盈率(LYR):-23.18

数据加载中...

2024/03/20

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities